Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 31722-710
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A bar graph illustrating the percentage of patients reporting improvement across four treatment groups: Placebo and Sildenafil Citrate Tablets at 25 mg, 50 mg, and 100 mg doses. The graph shows increasing improvement percentages with higher Sildenafil doses, with 24% for placebo, 63% for 25 mg, 74% for 50 mg, and 82% for 100 mg.*
Sildenafiltab100mg30s (Sildenafiltab100mg30s)
Label for Sildenafil 100 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label states the product is sold in a package of 30 tablets, with prescription use only. It includes storage instructions, manufacturer information, and a barcode.*
Sildenafiltab25mg30s (Sildenafiltab25mg30s)
Sildenafil Tablets, USP 25 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label indicates the quantity as 30 tablets and includes storage instructions for controlled room temperature. Manufacturer details and a barcode are also present. The right side includes a marked varnish area of 43 x 30 mm.*
Sildenafiltab50mg30s (Sildenafiltab50mg30s)
This image depicts a packaging label for Sildenafil Tablets, USP 50 mg film-coated tablets. The label shows the Camber Pharmaceuticals, Inc. logo and indicates a package containing 30 tablets. It includes storage instructions, dosage information, manufacturer details, and a barcode.*
Sildenafilfigure1 (Sildenafilfigure1)
A line graph comparing systolic blood pressure changes (mmHg) over 24 hours post-dose for Sildenafil 100 mg and placebo. The x-axis represents time in hours post dose, while the y-axis shows systolic blood pressure values, depicting trends for both treatments from pre-dose through 24 hours.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph comparing the change in a measured variable over time following dosing with placebo and 25 mg Sildenafil. The x-axis represents time postdose in hours, and the y-axis shows the change from baseline values. Data points for placebo and Sildenafil are plotted as distinct lines with markers.*
Sildenafilfigure3 (Sildenafilfigure3)
This line graph compares the change in systolic blood pressure over time after dosing for two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 50 mg. The x-axis represents time postdose in hours, and the y-axis shows the change in systolic blood pressure in mmHg. Data points are marked with blue circles for Doxazosin plus placebo and black triangles for Doxazosin plus Sildenafil 50 mg.*
Sildenafilfigure4 (Sildenafilfigure4)
A line graph depicting changes in mean arterial pressure (mm Hg) over time (hours) after dosing. It compares the effects of doxazosin combined with Sildenafil 100 mg and doxazosin combined with placebo, showing pressure variations up to 8 hours post-dose with respective data points connected by lines.*
Sildenafilfigure5 (Sildenafilfigure5)
A line graph depicting plasma concentration (ng/mL) of sildenafil over time (hours) post-dose. The X-axis represents time in hours up to 24 hours, while the Y-axis shows plasma concentration up to 500 ng/mL. Data points for a commercial tablet formulation are connected with a line, showing a peak concentration around 1 hour and a gradual decline thereafter.*
Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart showing the percentage of patients at endpoint across different baseline scores from 0 to 5. The chart uses multiple bars per baseline score grouped by categories labeled 0 through 5, representing distribution percentages for each group.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart showing the percentage of patients at endpoint across various baseline scores, with multiple data series represented by different shading patterns. The x-axis is labeled 'Baseline score' and ranges from 0 to 5, while the y-axis shows the percentage of patients. A legend on the right identifies the different data series with numerical labels from 0 to 5.*
Sildenafilheterologo1 (Sildenafilheterologo1)
Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafilstructure (Sildenafilstructure)
Chemical structure diagram of Sildenafil, showing its molecular composition and arrangement of rings, side chains, and functional groups as part of the drug's chemical identity.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
